Rigel Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Rigel Pharmaceuticals Stock Summary

Rigel Pharmaceuticals competes with Fortress Biotech, Reviva Pharmaceuticals, Pieris Pharmaceuticals, Cidara Therapeutics, and X4 Pharmaceuticals. Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California. Rigel Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 165 people.

Rigel Pharmaceuticals Key Financial Ratios

Rigel Pharmaceuticals Key Balance Sheet Accounts

Rigel Pharmaceuticals Key Income Statement Accounts

Rigel Pharmaceuticals Key Cash Accounts

Rigel Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Rigel Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Rigel Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rigel Pharmaceuticals competition to find correlations between indicators driving Rigel Pharmaceuticals's intrinsic value. More Info.Rigel Pharmaceuticals is rated below average in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers . At this time, Rigel Pharmaceuticals' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Rigel Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Rigel Pharmaceuticals Systematic Risk

Today, most investors in Rigel Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rigel Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Rigel Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Rigel Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Rigel Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rigel Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Rigel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rigel Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rigel Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.